WELITEL-AM combines Telmisartan 40 mg + Amlodipine 5 mg, offering complementary antihypertensive action for patients requiring additional blood-pressure control. A practical PCD Cardiac-Diabetic portfolio product.
Their complementary mechanisms can improve BP control.
Yes.
Follow the physician’s advice.
Monitor BP and report persistent swelling, severe dizziness or fainting. Take consistently as prescribed.
Dizziness, headache, flushing, fatigue and ankle edema may occur.
WELITEL-AM: Telmisartan blocks angiotensin-II-mediated vasoconstriction, while Amlodipine relaxes vascular smooth muscle through calcium-channel blockade.
